Significantly, disruption of senescence pathways, for example by inactivating tumor suppressors p53 or INK4a, results in a loss of these senescence markers and promotes malignant cancer progression, supporting the notion that cellular senescence suppresses cancer development in mice. The gene discussed is CDKN2A; the disease is cancer.